Otsuka coughs up $3.5bn for Avanir

Japanese firm Otsuka Pharmaceutical has agreed to acquire Avanir Pharmaceuticals, the California-based company that sells a reformulated cough and heart medicine combination to treat uncontrolled laughing and crying, for $3.5bn.